The purpose of this title is to address some of the complex and controversial issues posed by pharmaceutical marketing.

Specifically, articles in this work will address the impact of direct-to-consumer advertising of drugs, the marketing of drugs over the Internet, pharmaceutical companies' marketing policies, and the marketing of herbal products, which are not regulated by the United States Food and Drug Administration (FDA).

Hopefully, it will provide many new insights into the benefits and pitfalls of pharmaceutical marketing.
Originally published as Journal of Consumer Marketing (2005, Vol.22, No.7)